type here...
HomeNEWS

Coronavirus live updates | Phase-3 trial of Bharat Biotech’s Covaxin commences in AIIMS

AISNMA, the sole nodal agency for syringe manufacturers in India wrote to the Centre offering an additional capacity of over 350 million syringes per month in order to meet the entire demand for mass COVID-19 vaccination through domestic production.

Previous articleBombay HC dismisses plea seeking CBI probe into Disha Salian’s death
Next article‘One Nation, One Election’ need of India, says PM Modi

Similar Articles

India UAE Grow Bilateral Trade Amidst Worldwide Geopolitical Shifts

NEWS Editor -
Despite the growing geopolitical shifts and pandemic aftermaths hitting the economy, UAE and India relations have been growing strong. This became more and more...

Punjab: Sukhbir Badal’s vehicle attacked, SAD claims workers injured in firing

NEWS -
Sukhbir Badal's vehicle attacked, SAD claims workers injured in firing

Most Popular

India Daily Live is your news, entertainment, music fashion website. We provide you with the latest breaking news and videos straight from the entertainment industry.

© Copyright - Newspaper WordPress Theme by TagDiv